M. Fujisaki

发表

Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia

K. Hashimoto, M. Iyo, Y. Shirayama, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Does hypofrontality expand to global brain area in progression of schizophrenia?: A cross-sectional study between first-episode and chronic schizophrenia

N. Kanahara, K. Hashimoto, M. Iyo, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine

D. Matsuzawa, C. Sutoh, S. Matsuda, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

High Occupancy of Sigma-1 Receptors in the Human Brain after Single Oral Administration of Fluvoxamine: A Positron Emission Tomography Study Using [11C]SA4503

K. Hashimoto, M. Iyo, E. Shimizu, 2007, Biological Psychiatry.

igh Occupancy of Sigma-1 Receptors in the Human rain after Single Oral Administration of Fluvoxamine : Positron Emission Tomography Study Using 11 C ] SA 4503

K. Hashimoto, M. Iyo, K. Ishii, 2007 .

Alterations in serum amino acid concentrations in male and female schizophrenic patients.

K. Hashimoto, M. Iyo, T. Toyo’oka, 2007, Clinica chimica acta; international journal of clinical chemistry.

Combined intoxication with methylone and 5-MeO-MIPT

K. Hashimoto, M. Iyo, E. Shimizu, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Expert consensus on hospitalization for assessment: a survey in Japan for a new forensic mental health system

M. Iyo, Y. Oda, Y. Igarashi, 2011, Annals of general psychiatry.

Attitudes of Japanese psychiatrists toward forensic mental health as revealed by a national survey

M. Iyo, Naoe Okamura, Y. Igarashi, 2011, Psychiatry and clinical neurosciences.

Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects

K. Hashimoto, M. Iyo, Y. Shirayama, 2010, Annals of general psychiatry.

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

N. Kanahara, K. Hashimoto, M. Iyo, 2010, Annals of general psychiatry.

Deficits in auditory P50 inhibition in obsessive–compulsive disorder

D. Matsuzawa, N. Kanahara, K. Hashimoto, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia: A Preliminary Study

N. Kanahara, K. Hashimoto, M. Iyo, 2012, Journal of clinical psychopharmacology.

Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia

D. Matsuzawa, N. Kanahara, K. Hashimoto, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Fluvoxamine improved cognitive impairments in a patient with schizophrenia

K. Hashimoto, M. Iyo, Y. Shirayama, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and novelty seeking personality in healthy females

K. Hashimoto, M. Iyo, E. Shimizu, 2006, Progress in Neuro-psychopharmacology and Biological Psychiatry.

Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits.

Kenji Hashimoto, Daisuke Matsuzawa, Masaomi Iyo, 2007, Journal of psychiatric research.

An open trial of outpatient group therapy for bulimic disorders: Combination program of cognitive behavioral therapy with assertive training and self‐esteem enhancement

M. Iyo, E. Shimizu, M. Mitsumori, 2005, Psychiatry and clinical neurosciences.

Beyond Binder: Determination of criminal responsibility while in a state of drunkenness by Japanese courts

M. Iyo, M. Fujisaki, A. Shiina, 2012 .

Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia

K. Hashimoto, M. Iyo, E. Shimizu, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Functional Polymorphism of the Glutathione Peroxidase 1 Gene Is Associated with Personality Traits in Healthy Subjects

D. Matsuzawa, K. Hashimoto, M. Iyo, 2005, Neuropsychobiology.

Alterations of Responsibility Beliefs Through Cognitive-Behavioural Group Therapy for Obsessive-Compulsive Disorder

M. Iyo, E. Shimizu, Goro Fukami, 2011, Behavioural and Cognitive Psychotherapy.

Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia

D. Matsuzawa, N. Kanahara, K. Hashimoto, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

N. Kanahara, K. Hashimoto, M. Iyo, 2010, Annals of general psychiatry.

Role of the amygdalo-hippocampal transition area in the fear expression: evaluation by behavior and immediate early gene expression

K. Hashimoto, M. Iyo, T. Chiba, 2004, Neuroscience.